Objective: While clozapine-associated agranulocytosis has received extensive attention, a number of recent publications have identified that the incidence of eosinophilia may also be of concern. This retrospective review identifies the incidence of eosinophilia within a group of people commencing clozapine at a large hospital in Australia.
Method: The pathology reports of all people (n = 160) who commenced clozapine within a 3.5–year period were retrospectively reviewed for incidences of eosinophilia. Results: The incidence of eosinophilia was identified as 13%, comprising 17 males and four females. All cases of eosinophilia developed within 4 weeks of commencing clozapine. One male reached a peak eosinophil level of 9 × 109/L, which resolved after clozapine was withdrawn. In all other cases, the eosinophilia resolved without intervention.
Conclusions: With a rate of eosinophilia at 13% in this population under review, and given that there have been reports of 25 cases of eosinophilic cardiomyopothy resulting in four deaths worldwide, clinicians should be alert to the incidence and sequelae of eosinophilia in people receiving clozapine treatment.
KaneJHonigfeldGSingerJMeltzerH.Clozapine for the treatment-resistant schizophrenia. Archives of General Psychiatry1988; 45:789–796.
2.
AlvirJMJLiebermanJASaffermanAZSchwimmerJLClozapine-induced agranulocytosis. Incidence and risk factors in the United States. New England Journal of Medicine1993; 329:162–167.
3.
FrankenburgFRKandoJ.Eosinophilia, clozapine and pancreatitis. Lancet1992; 340:251.
4.
MartinA.Acute pancreatitis associated with clozapine use. American Journal of Psychiatry1992; 149:714.
5.
FriedbergJWFrankenburgFRBurkJJohnsosW.Clozapine-caused eosinophilic colitis. Annals of Clinical Psychiatry1995; 7:97–98.
6.
BanovMDTohenMFriedbergJ.High risk of eosinophilia in women treated with clozapine. Journal of Clinical Psychiatry1993; 54:466–469.
7.
LaderM.Experience with clozapine in the United Kingdom. Presented at the NIMH New Clinical Drug Evaluation Unit Program, 31st Annual Meeting. Key Biscayne, Florida, 28–31 May 1991.
8.
TihonenJPaanilaJ.Eosinophilia associated with clozapine. Lancet1992; 399:488.
9.
WellerPFThe immmunobiology of eosinophilia. New England Journal of Medicine1991; 324:1110–1118.
10.
GalletlyCWilsonDMcEwenS.Eosinophilia associated with decreasing neutrophil count in a clozapine-treated patient. Journal of Clinical Psychiatry1995; 57:140–41.
11.
AmesDCarterJWWirshingWCMarderSRGoldsteinMJClozapine associated eosinophilia and neutropenia. Schizophrenia Research1995; 15:141–142.
12.
FauciASThe idiopathic hypereosinophilic syndrome: clinical, pathophysiologic and therapeutic considerations. Annals of Internal Medicine1982; 97:78–92.
